Efficacy News and Research

RSS
R-Tech Ueno announces completion of RK-023 Phase 2a study for androgenetic alopecia

R-Tech Ueno announces completion of RK-023 Phase 2a study for androgenetic alopecia

Bayer's gadobutrol injection for CNS imaging receives FDA Advisory Committee approval

Bayer's gadobutrol injection for CNS imaging receives FDA Advisory Committee approval

SuppreMol completes successful pre-IND meeting with U.S. FDA

SuppreMol completes successful pre-IND meeting with U.S. FDA

CRI, Oncovir sign new investment agreement to produce immunological stimulant

CRI, Oncovir sign new investment agreement to produce immunological stimulant

First U.S. implant of RespiCardia System for treatment of sleep apnea

First U.S. implant of RespiCardia System for treatment of sleep apnea

CVAF completes new investment agreement with Oncovir for production of Hiltonol

CVAF completes new investment agreement with Oncovir for production of Hiltonol

Approaches designed to motivate drug development for children needed

Approaches designed to motivate drug development for children needed

RBM, SMA Foundation collaborate to develop plasma protein biomarkers for spinal muscular atrophy

RBM, SMA Foundation collaborate to develop plasma protein biomarkers for spinal muscular atrophy

EDAP announces placement of first Sonolith i-sys electroconductive lithotripter in South Africa

EDAP announces placement of first Sonolith i-sys electroconductive lithotripter in South Africa

Major breakthrough: Genome-based medicine for treatment of alcoholism

Major breakthrough: Genome-based medicine for treatment of alcoholism

Health Canada approves Labopharm's OLEPTRO for treatment of Major Depressive Disorder

Health Canada approves Labopharm's OLEPTRO for treatment of Major Depressive Disorder

Positive results from nimotuzumab Phase II study for gastric cancer

Positive results from nimotuzumab Phase II study for gastric cancer

FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA

FDA provides tentative approval under PEPFAR for Matrix's Lamivudine and Zidovudine NDA

FDA grants Soligenix Orphan Drug Designation to RiVax for prevention of ricin intoxication

FDA grants Soligenix Orphan Drug Designation to RiVax for prevention of ricin intoxication

Chelsea reports top-line data from Phase III NORTHERA extension study in NOH

Chelsea reports top-line data from Phase III NORTHERA extension study in NOH

Merck provides additional information about DSMB recommendations for vorapaxar TRA-2P study

Merck provides additional information about DSMB recommendations for vorapaxar TRA-2P study

ISCT launches commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease

ISCT launches commercial development focus group addressing Cell Therapies for Peripheral Vascular Disease

Pervasis pursues matrix-embedded endothelial cell-based therapy to target and regulate cell stroma

Pervasis pursues matrix-embedded endothelial cell-based therapy to target and regulate cell stroma

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

UMB enters license agreement with Bali BioSciences for new strategy to combat sepsis, HIV/AIDS

Precision Therapeutics to present pancreatic cancer data at 2011 ASCO GI Symposium

Precision Therapeutics to present pancreatic cancer data at 2011 ASCO GI Symposium

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.